Öberg K, Knigge U, Kwekkeboom D, Perren A, 외. (ESMO Guidelines Working Group) (October 2012). “Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”. 《Annals of Oncology》. 23 Suppl 7 (suppl 7): vii124–30. doi:10.1093/annonc/mds295. PMID22997445. (Table 5 outlines the proposed TNM staging system for PanNETs.)
“What Is Cancer? Defining Cancer”. National Cancer Institute, National Institutes of Health. 2014년 3월 7일. 2014년 6월 25일에 원본 문서에서 보존된 문서. 2014년 12월 5일에 확인함.
“Pancreatic Cancer Treatment (PDQ®) Health Professional Version”. National Cancer Institute. National Institutes of Health. 2014년 2월 21일. 2014년 10월 22일에 원본 문서에서 보존된 문서. 2014년 11월 24일에 확인함. "The highest cure rate occurs if the tumor is truly localized to the pancreas; however, this stage of disease accounts for less than 20% of cases. In cases with localized disease and small cancers (<2 cm) with no lymph-node metastases and no extension beyond the capsule of the pancreas, complete surgical resection is still associated with a low actuarial five-year survival rate of 18% to 24%."
“Cancer Facts and Figures 2014”(PDF). 《American Cancer Society》. 2014년 12월 18일에 원본 문서(PDF)에서 보존된 문서. 2015년 1월 5일에 확인함., p. 19, "Though evidence is still accumulating, consumption of red or processed meat, or meat cooked at very high temperatures, may slightly increase risk."
“Pancreatic cancer statistics”. 《Cancer Research UK》. 2014년 12월 18일에 원본 문서에서 보존된 문서. 2014년 12월 18일에 확인함.; "In 2010, in the UK, the lifetime risk of developing pancreatic cancer is 1 in 73 for men and 1 in 74 for women", noting "The lifetime risk ... has been calculated ... using the 'Current Probability' method; this is a different method used from most other cancer sites since the possibility of having more than one diagnosis of pancreatic cancer over the course of their lifetime is very low"
cancerstaging.org
〈Chapter 15; Pancreas〉(PDF). 《Manual for Staging of Cancer》 2판. American Joint Committee on Cancer. 95–98쪽. 29 November 2014에 원본 문서(PDF)에서 보존된 문서. See p. 95 for citation regarding "... lesser degree of involvement of bones and brain and other anatomical sites."
Ryan DP, Hong TS, Bardeesy N (September 2014). “Pancreatic adenocarcinoma”. 《The New England Journal of Medicine》 371 (11): 1039–49. doi:10.1056/NEJMra1404198. PMID25207767.
Rohrmann, Sabine; 외. (2013). “Meat and fish consumption and risk of pancreatic cancer: Results from the European Prospective Investigation into Cancer and Nutrition”. 《International Journal of Cancer》 132 (3): 617–624. doi:10.1002/ijc.27637. PMID22610753. S2CID2613568.
Bardou M, Le Ray I (December 2013). “Treatment of pancreatic cancer: A narrative review of cost-effectiveness studies”. 《Best Practice & Research Clinical Gastroenterology》 27 (6): 881–92. doi:10.1016/j.bpg.2013.09.006. PMID24182608.
Öberg K, Knigge U, Kwekkeboom D, Perren A, 외. (ESMO Guidelines Working Group) (October 2012). “Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”. 《Annals of Oncology》. 23 Suppl 7 (suppl 7): vii124–30. doi:10.1093/annonc/mds295. PMID22997445. (Table 5 outlines the proposed TNM staging system for PanNETs.)
Farrell JJ, Fernández-del Castillo C (June 2013). “Pancreatic cystic neoplasms: management and unanswered questions”. 《Gastroenterology》 144 (6): 1303–15. doi:10.1053/j.gastro.2013.01.073. PMID23622140.
The PanNET denomination is in line with WHO guidelines for the classification of tumors of the digestive system “WHO classification of tumours of the digestive system – NLM Catalog – NCBI”. 2017년 9월 9일에 원본 문서에서 보존된 문서. 2017년 9월 7일에 확인함. published in 2010. Historically, PanNETs have also been referred to by a variety of terms, and are still commonly called "pancreatic endocrine tumors". See: Klimstra DS, Modlin IR, Coppola D, Lloyd RV, Suster S (August 2010). “The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems”. 《Pancreas》 39 (6): 707–12. doi:10.1097/MPA.0b013e3181ec124e. PMID20664470. S2CID3735444.
Burns WR, Edil BH (March 2012). “Neuroendocrine pancreatic tumors: guidelines for management and update”. 《Current Treatment Options in Oncology》 13 (1): 24–34. doi:10.1007/s11864-011-0172-2. PMID22198808. S2CID7329783.
Rooney SL, Shi J (October 2016). “Intraductal Tubulopapillary Neoplasm of the Pancreas: An Update From a Pathologist's Perspective”. 《Archives of Pathology & Laboratory Medicine》 140 (10): 1068–73. doi:10.5858/arpa.2016-0207-RA. PMID27684978.
Uhlen M, Zhang C, Lee S, Sjöstedt E, Fagerberg L, Bidkhori G, 외. (August 2017). “A pathology atlas of the human cancer transcriptome”. 《Science》 357 (6352): eaan2507. doi:10.1126/science.aan2507. PMID28818916.
Lewis MA, Yao JC (February 2014). “Molecular pathology and genetics of gastrointestinal neuroendocrine tumours”. 《Current Opinion in Endocrinology, Diabetes and Obesity》 21 (1): 22–27. doi:10.1097/MED.0000000000000033. PMID24310147. S2CID31094880.
Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR, 외. (September 2012). “Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)”. 《The Journal of Clinical Endocrinology and Metabolism》 97 (9): 2990–3011. doi:10.1210/jc.2012-1230. PMID22723327.
“Types of Pancreas Tumors”. 《The Sol Goldman Pancreas Cancer Research Center》. Johns Hopkins Medicine. 2012. 8 October 2014에 원본 문서에서 보존된 문서. 18 November 2014에 확인함.
“Causes of pancreatic cancer”. 《NHS Choices》. National Health Service, England. 2014년 10월 7일. 2014년 11월 6일에 원본 문서에서 보존된 문서. 2014년 12월 5일에 확인함.
nih.gov
ncbi.nlm.nih.gov
Ryan DP, Hong TS, Bardeesy N (September 2014). “Pancreatic adenocarcinoma”. 《The New England Journal of Medicine》 371 (11): 1039–49. doi:10.1056/NEJMra1404198. PMID25207767.
Rohrmann, Sabine; 외. (2013). “Meat and fish consumption and risk of pancreatic cancer: Results from the European Prospective Investigation into Cancer and Nutrition”. 《International Journal of Cancer》 132 (3): 617–624. doi:10.1002/ijc.27637. PMID22610753. S2CID2613568.
Bardou M, Le Ray I (December 2013). “Treatment of pancreatic cancer: A narrative review of cost-effectiveness studies”. 《Best Practice & Research Clinical Gastroenterology》 27 (6): 881–92. doi:10.1016/j.bpg.2013.09.006. PMID24182608.
Öberg K, Knigge U, Kwekkeboom D, Perren A, 외. (ESMO Guidelines Working Group) (October 2012). “Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”. 《Annals of Oncology》. 23 Suppl 7 (suppl 7): vii124–30. doi:10.1093/annonc/mds295. PMID22997445. (Table 5 outlines the proposed TNM staging system for PanNETs.)
Farrell JJ, Fernández-del Castillo C (June 2013). “Pancreatic cystic neoplasms: management and unanswered questions”. 《Gastroenterology》 144 (6): 1303–15. doi:10.1053/j.gastro.2013.01.073. PMID23622140.
The PanNET denomination is in line with WHO guidelines for the classification of tumors of the digestive system “WHO classification of tumours of the digestive system – NLM Catalog – NCBI”. 2017년 9월 9일에 원본 문서에서 보존된 문서. 2017년 9월 7일에 확인함. published in 2010. Historically, PanNETs have also been referred to by a variety of terms, and are still commonly called "pancreatic endocrine tumors". See: Klimstra DS, Modlin IR, Coppola D, Lloyd RV, Suster S (August 2010). “The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems”. 《Pancreas》 39 (6): 707–12. doi:10.1097/MPA.0b013e3181ec124e. PMID20664470. S2CID3735444.
Burns WR, Edil BH (March 2012). “Neuroendocrine pancreatic tumors: guidelines for management and update”. 《Current Treatment Options in Oncology》 13 (1): 24–34. doi:10.1007/s11864-011-0172-2. PMID22198808. S2CID7329783.
De La Cruz MS, Young AP, Ruffin MT (April 2014). “Diagnosis and management of pancreatic cancer”. 《American Family Physician》 89 (8): 626–32. PMID24784121.
Rooney SL, Shi J (October 2016). “Intraductal Tubulopapillary Neoplasm of the Pancreas: An Update From a Pathologist's Perspective”. 《Archives of Pathology & Laboratory Medicine》 140 (10): 1068–73. doi:10.5858/arpa.2016-0207-RA. PMID27684978.
Uhlen M, Zhang C, Lee S, Sjöstedt E, Fagerberg L, Bidkhori G, 외. (August 2017). “A pathology atlas of the human cancer transcriptome”. 《Science》 357 (6352): eaan2507. doi:10.1126/science.aan2507. PMID28818916.
Lewis MA, Yao JC (February 2014). “Molecular pathology and genetics of gastrointestinal neuroendocrine tumours”. 《Current Opinion in Endocrinology, Diabetes and Obesity》 21 (1): 22–27. doi:10.1097/MED.0000000000000033. PMID24310147. S2CID31094880.
Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR, 외. (September 2012). “Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)”. 《The Journal of Clinical Endocrinology and Metabolism》 97 (9): 2990–3011. doi:10.1210/jc.2012-1230. PMID22723327.
Rohrmann, Sabine; 외. (2013). “Meat and fish consumption and risk of pancreatic cancer: Results from the European Prospective Investigation into Cancer and Nutrition”. 《International Journal of Cancer》 132 (3): 617–624. doi:10.1002/ijc.27637. PMID22610753. S2CID2613568.
The PanNET denomination is in line with WHO guidelines for the classification of tumors of the digestive system “WHO classification of tumours of the digestive system – NLM Catalog – NCBI”. 2017년 9월 9일에 원본 문서에서 보존된 문서. 2017년 9월 7일에 확인함. published in 2010. Historically, PanNETs have also been referred to by a variety of terms, and are still commonly called "pancreatic endocrine tumors". See: Klimstra DS, Modlin IR, Coppola D, Lloyd RV, Suster S (August 2010). “The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems”. 《Pancreas》 39 (6): 707–12. doi:10.1097/MPA.0b013e3181ec124e. PMID20664470. S2CID3735444.
Burns WR, Edil BH (March 2012). “Neuroendocrine pancreatic tumors: guidelines for management and update”. 《Current Treatment Options in Oncology》 13 (1): 24–34. doi:10.1007/s11864-011-0172-2. PMID22198808. S2CID7329783.
Greenhalf W, Grocock C, Harcus M, Neoptolemos J (May 2009). “Screening of high-risk families for pancreatic cancer”. 《Pancreatology》 9 (3): 215–22. doi:10.1159/000210262. PMID19349734. S2CID29100310.
Lewis MA, Yao JC (February 2014). “Molecular pathology and genetics of gastrointestinal neuroendocrine tumours”. 《Current Opinion in Endocrinology, Diabetes and Obesity》 21 (1): 22–27. doi:10.1097/MED.0000000000000033. PMID24310147. S2CID31094880.
“What Is Cancer? Defining Cancer”. National Cancer Institute, National Institutes of Health. 2014년 3월 7일. 2014년 6월 25일에 원본 문서에서 보존된 문서. 2014년 12월 5일에 확인함.
“Pancreatic Cancer Treatment (PDQ®) Health Professional Version”. National Cancer Institute. National Institutes of Health. 2014년 2월 21일. 2014년 10월 22일에 원본 문서에서 보존된 문서. 2014년 11월 24일에 확인함. "The highest cure rate occurs if the tumor is truly localized to the pancreas; however, this stage of disease accounts for less than 20% of cases. In cases with localized disease and small cancers (<2 cm) with no lymph-node metastases and no extension beyond the capsule of the pancreas, complete surgical resection is still associated with a low actuarial five-year survival rate of 18% to 24%."
“Types of Pancreas Tumors”. 《The Sol Goldman Pancreas Cancer Research Center》. Johns Hopkins Medicine. 2012. 8 October 2014에 원본 문서에서 보존된 문서. 18 November 2014에 확인함.
The PanNET denomination is in line with WHO guidelines for the classification of tumors of the digestive system “WHO classification of tumours of the digestive system – NLM Catalog – NCBI”. 2017년 9월 9일에 원본 문서에서 보존된 문서. 2017년 9월 7일에 확인함. published in 2010. Historically, PanNETs have also been referred to by a variety of terms, and are still commonly called "pancreatic endocrine tumors". See: Klimstra DS, Modlin IR, Coppola D, Lloyd RV, Suster S (August 2010). “The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems”. 《Pancreas》 39 (6): 707–12. doi:10.1097/MPA.0b013e3181ec124e. PMID20664470. S2CID3735444.
〈Chapter 15; Pancreas〉(PDF). 《Manual for Staging of Cancer》 2판. American Joint Committee on Cancer. 95–98쪽. 29 November 2014에 원본 문서(PDF)에서 보존된 문서. See p. 95 for citation regarding "... lesser degree of involvement of bones and brain and other anatomical sites."
“Causes of pancreatic cancer”. 《NHS Choices》. National Health Service, England. 2014년 10월 7일. 2014년 11월 6일에 원본 문서에서 보존된 문서. 2014년 12월 5일에 확인함.
“Cancer Facts and Figures 2014”(PDF). 《American Cancer Society》. 2014년 12월 18일에 원본 문서(PDF)에서 보존된 문서. 2015년 1월 5일에 확인함., p. 19, "Though evidence is still accumulating, consumption of red or processed meat, or meat cooked at very high temperatures, may slightly increase risk."
“Pancreatic cancer statistics”. 《Cancer Research UK》. 2014년 12월 18일에 원본 문서에서 보존된 문서. 2014년 12월 18일에 확인함.; "In 2010, in the UK, the lifetime risk of developing pancreatic cancer is 1 in 73 for men and 1 in 74 for women", noting "The lifetime risk ... has been calculated ... using the 'Current Probability' method; this is a different method used from most other cancer sites since the possibility of having more than one diagnosis of pancreatic cancer over the course of their lifetime is very low"